Antelope Valley Cancer Center

Lancaster, California 93534

0 studies enrolling now · 9 studies all time

What they study most

Breast Cancer, Carcinoma, Non-Small-Cell Lung, Chronic Myeloid Leukemia, Esophageal Cancer, Gastric Cancer, Lung Cancer, Multiple Myeloma, Neoplasms, Lung, Neoplasms, Pulmonary, Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL), Non-small-cell Lung Carcinoma

Studies at this site

• TAC Versus TC for Adjuvant Breast Cancer — Completed
• A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer — Completed
• BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab — Stopped early
• Everolimus in Treating Patients With Previously Treated Unresectable or Metastatic Esophageal Cancer or Stomach Cancer — Completed
• Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients — Completed
• A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) — Completed
• Expanded Access Program of AMN107 in Imatinib-resistant or Intolerant Adult Patients With Chronic Myeloid Leukemia — NO_LONGER_AVAILABLE
• A Multiple Myeloma Trial in Patients With Bone Metastases — Completed
• Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy — Stopped early